Browsing by Author Luk, F

Showing results 1 to 20 of 23  next >
Issue DateTitleAuthor(s)
1-Jul-2016Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)Krishnan, SR; Jaiswal, R; Brown, RD; Luk, F; Bebawy, M
1-Sep-2015Multiple myeloma: A novel tailor-made therapeutic management.Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL
1-Aug-2015Microparticles as novel prognostic markers in multiple myelomaRajeev Krishnan, S; Bebawy, M; Brown, RD; Luk, F; Kwan, Y
1-May-2015Targeting microparticle biogenesis: A novel approach to the circumvention of cancer multidrug resistanceRoseblade, A; Luk, F; Ung, A; Bebawy, M
1-Apr-2015Microparticles in cancer: A review of recent developments and the potential for clinical applicationGong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
Apr-2015Microparticles in cancer: A review of recent developments and the potential for clinical applicationGong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
15-Feb-2015Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancerGong, J; Luk, F; Jaiswal, R; Bebawy, M
15-Feb-2015A novel personalized therapeutic management in multiple myelomaKrishnan, RS; Luk, F; Brown, RD; Kwan, YL; Bebawy, M
15-Feb-2015Functional translation of total RNA packaged in microparticles shed from multidrug resistant cancer cellsLu, JF; Pokharel, D; Luk, F; Bebawy, M
1-Jan-2015Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activityLee, WH; Bebawy, M; Loo, CY; Luk, F; Mason, RS; Rohanizadeh, R
Aug-2014SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPYLee, W-H; Ong, H-X; Loo, C-Y; Traini, D; Young, PM; Luk, F; Bebawy, M; Rohanizadeh, R
1-Jan-2014Proteome analysis of multidrug-resistant, breast cancer-derived microparticlesPokharel, D; Padula, MP; Lu, JF; Tacchi, JL; Luk, F; Djordjevic, SP; Bebawy, M
1-Jan-2014Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cellsGong, J; Luk, F; Jaiswal, R; Bebawy, M
1-Jan-2014Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy?Callaghan, R; Luk, F; Bebawy, M
17-Dec-2013Cell-derived microparticles: New targets in the therapeutic management of diseaseRoseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M
5-Dec-2013Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, GER; Bebawy, M
1-Oct-2013Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21<sup>st</sup>centuryLee, WH; Loo, CY; Bebawy, M; Luk, F; Mason, RS; Rohanizadeh, R
2-Sep-2013Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathwaysLu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, GER; Bebawy, M
12-Apr-2013Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to CellsJaiswal, R; Luk, F; Dalla, PV; Grau, GER; Bebawy, M
Jan-2013Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M